Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

Clinical trial NCT07444567 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07444567
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Asthma Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilic Syndrome (HES)

Start date: 2026-05-25
Primary completion: 2029-12-28
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.